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Costs and cost-
effectiveness of alternative
tuberculosis management
strategies in South Africa
- implications for policy
David Wilkinson, Katherine Floyd, Charles F Gilks
Objective. To conduct an economic analysis of the Hlabisa
community-based directly observed therapy management
strategy for tuberculosis and to project costs of three
alternative strategies.
Setting. Hlabisa health district, Kwazulu-Natal, South
Africa.
Methods. An economic analysis comparing the current
tuberculosis management strategy in Hlabisa with three
alternative strategies (the Hlabisa strategy prior to 1991
based on hospitalisation, the national strategy and
sanatorium care) in terms of costs to both health service
and patient and of cost-effectiveness.
Results. The current Hlabisa strategy was the most
cost-effective (R3 799 per patient cured), compared with
R98 307 for the strategy used prior to 1991, R9 940 for the
national strategy, and R11 145 for sanatorium care.
Between 71 % and 88% of treatment costs lie with the
health service, and hospitalisation (R119 per day) is the
most expensive item. Prolonged hospitalisation is
extremely expensive, but community care is cheaper
(community clinic visit, R28; community health worker
visit, Rl). The total cost of supervising a patient in the
community under the current Hlabisa strategy was R503,
equivalent to 4.2 days in hospital. Drug costs (R157) are
equivalent to just 1.3 days in hospital.
Conclusion. Cost to both health service and patient can
be substantially reduced by using community-based
directly observed therapy for tuberculosis, a strategy that
is cheap and cost-effective in Hlabisa. These findings have
important national implications, supporting the goals of
the new tuberculosis control programme.
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With around 100 000 cases each year, tuberculosis is the
most frequently notified disease in South Africa.' Incidence,
at around 300 per 100 000 population, is one of the highest
rates in the world. In sub-Saharan African countries that are
hardest hit by the HIV epidemic, tuberculosis incidence has
increased dramatically.2 The impact of HIV on tuberculosis in
South Africa is not yet reflected in notification data.
However, in Hlabisa in northern Kwalulu-Natal - the
province with the highest HIV prevalence3 - the number of
patients admitted between 1991 and 1996 increased
threefold. In 1995, 58% of adults with tuberculosis in
Hlabisa were HIV infected." With coincident high rates of
tuberculosis and HIV infection, South Africa will inevitably
face a much increased burden of tuberculosis in the near
future. The impact that this will have on the high prevalence
of multidrug resistance in some parts of the country is of
serious concern.s
The Department of Health has adopted a tuberculosis
control programme based on that advocated by the World
Health Organisation and the International Union Against
Tuberculosis and Lung Disease (IUATLD),5 recommending
ambulatory care. The redesign of tuberculosis control in
South Africa is to be welcomed as the previous fragmented
and unco-ordinated approach was unsatisfactory. Treatment
completion rates - although not known in detail for most of
the country - are generally considered inadequate.1
Through a simplified approach to tuberculosis management,S
which entails intermittent community-based directly
observed therapy, the Hlabisa tuberculosis control
programme achieved an 85% completion of treatment rate
between 1991 and 1994.9 Associated rates of drug
resistance are low1o and the cure rate among those
completing treatment is 95%.11
With increasing caseloads and constrained budgets, the
relative cost-effectiveness of alternative strategies should
inform policy decisions about what form tuberculosis control
in South Africa will take. We conducted a detailed costing
analysis of the Hlabisa tuberculosis control programme, and
used these data to estimate costs of three alternative
strategies.
Methods
The study took place in the Hlabisa health district of
Kwazulu-Natal in May 1996.
Alternative strategies
Four different tuberculosis control strategies were
compared. The current approach used in Hlabisa (strategy 1)
was compared with the strategy in place in Hlabisa prior to
1991 (strategy 2) in order to gain insight into the impact of
introducing community-based directly observed therapy in a
district and because strategy 2 reflects what is currently in
place in much of South Africa. 1 The projected cost and cost-
effectiveness of the national policy (strategy 3) were also
compared. as was the strategy used by the South African
National Tuberculosis Association (SANTA) whereby patients
are managed as inpatients in a sanatorium. The essential
components of the four strategies are outlined in Table I. For
simplicity, and because this group is the most important
from a public heaJth perspective, our analysis refers to the
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\period following diagnosis of new adult cases of
tuberculosis. Costs of treating children and retreatment
cases differed little (data not shown).
The current HJabisa programme (strategy 1) and its results
have been described.~·'} In brief, all patients are admitted for
a minimum of 2 weeks (average length of stay is 17.5 days),
during which time they receive four drugs daily (Table I). All
patients are eligible for community-based directly observed
therapy, and in 199490% received it.'} The same four drugs
are then given in a high dose twice weekly as directly
observed therapy in the community. On discharge aJl
patients are transported to their supervisor. The supervisor is
chosen by the patient on the basis of closeness to his
home or workplace. and the supervisor holds all the
treatment packs required to complete a 6-month course of
therapy. The patient visits his supervisor twice weekly and
ingests the treatment under direct observation. A fieldworker
visits each supervisor monthly to collect patient outcome
data and to trace absconders. Patients are supervised either
by health workers (clinic nurses and community health
workers) or voluntary non-health workers (mainly
storekeepers): in 1994, 56% were supervised by volunteers.s
Patients are not routinely seen during treatment A medical
officer devotes 20% of his time to management of the
programme, the tuberculosis ward is staffed by various
grades of nurse, and there are two fieldstaff who use a
vehicle two or three times each week.
The previous approach used in Hlabisa (strategy 2) -
typical of that currently used in many parts of South Africa'
- relied on a lengthy period of hospital admission. Patients
took four drugs daily for 4 months as inpatients, followed by
a further 4 months of unsupervised daily outpatient therapy
with two drugs (collecting treatment from a clinic monthly).
Smears and chest radiographs were performed monthly
during admission, and patients were invited to return for the
same on completion of therapy. No active programme
management was undertaken and a treatment completion
rate of 18% for patients treated in 1990 was documented
from a record review undertaken in 1991.
The guidelines provided by the Department of HealthT~ do
not dictate an exact programme structure at district level.
Rather, they provide guidance on various aspects of
implementation of the new control programme. In parts, the
guidelines set out what should be done (e.g. smear
examination at certain times, drug regimens to be used), in
other parts they are less clear (e.g. length of hospitalisation,
supervision arrangements). To compare the national strategy
with the two Hlabisa strategies we assumed a 'best-case'
scenario for effectiveness of the national strategy at 91 %
cure rate, as this has been achieved in some IUATLD model
programmes from which this strategy is drawn. '3 In other
model programmes cure rates are considerably fower.'4 The
national goal is cure of 85% of all smear-positive cases.'2 As
the IUATLD programmes rely on an initial 2-month hospital
stay as a way of improving compliance, and as this is done
in many parts of South Africa,; we costed strategy 3
accordingly. We recognise that different provinces use
differing periods of admission and the effect of this can be
Table I. Summary of components of alternative tuberculosis management strategies
Number of visits to
Drug collect piffs or to
Drug Sputum sensitivity Hospital take therapy under Programme
Strategy regimen- examination X-rays testing stay direct observation Supervision management
Hlabisa 6HRZE No routine None Not Minimum Twice a week to a Two fieldworkers 20% of
(1991- for examination routinely done 2 weeks named supervisor to organise 1 medical
current) adults after after (average for DOT to supervision. officer's time
diagnosis diagnosis 17.5 days) complete Average 14
treatment community trips
per month with
vehicle and driver
to deliver patients
and to supervise
supervisors
Hlabisa 4HRZE Monthly Monthly Not Initial Once a month to a Not part Not part
(until +4HE during during done 4 months clinic to collect a of the of the
1991) therapy therapy of l-month supply management management
and at and at therapy during the second strategy strategy
end of end of 4 months of therapy
treatment therapy
Depart- 2HRZE Examined None Not Not Five times a week in Not specified Programme
ment of +4HR at 2 months, routinely routine specified the intensive phase audit and
Health at 3 months after of therapy for all record~
if one sputum diagnosis non~hospitalised keeping
still positive at patients; 3 - 5 times seen as
2 months, at a week in the essential
5 months and continuation phase
at 6 months of treatment
SANTA Follows Follows Varies Not Until NJA N/A Inpatient
national national according routine cure stay
guidelines guidelines to clinician
• Numbers refet" to duration of therapy in months.
H " isooiazid; R " mampicin; Z " pyrazifl<1ITlide: E " ethambutol; DOT " directly observed thetapy.
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extrapolated from the data presented. Ambulatory care is
recommended for new patients but it is not clear how, or if,
this will be achieved nationally.
Many patients are still treated in sanatoria in South
Africa. SANTA, which plays a major role advocating a
positive societal response to tuberculosis, until recently
depended in large part on full inpatient stay to treat patients.
This study was not designed to assess in detail the cost of
sanatoria-based care, but rather to provide a reasonable
means of comparison with the other strategies. The
structure of care in terms of frequency of smear
examinations and drug regimen was assumed to be similar
to the national strategy.
Effectiveness measure
The ideal measure of effectiveness is the bacteriological
cure rate. The cure rate for strategy 1 is 81 % {95% of the
85% that complete treatment);'l11 for strategy 2 it is
estimated at 17% (95% of the 18% that completed
treatment), and for strategy 3 it is 91%.13 We assumed a
cure rate of 95% for strategy 4.
Costing analysis
Costs incurred by the health service and the patient were
determined in detail for strategy 1. These are reported in
detail elsewhere'S and are summarised here. We then used
these data to estimate the costs of strategies 2 and 3 were
they to be implemented in Hlabisa now. The actual
components of each strategy are similar - hospital stay,
sputum examination, X-ray examination, outpatient or
supervisor visits, supervision of supervisors, drugs and.
programme management. What varies is whether each
component is included in the strategy, the details of each
component (e.g. type of drug regimen) and its relative
importance (e.g. length of hospital stay). For strategy 4,
economies of scale operate and castings estimated by
SANTA were used (M Stafford, SANTA - personal
communication). These were estimated to be R40 per
patient per day. It was assumed that patient costs were
independent of the management strategy used.
Health system cost data were obtained from a variety of
sources including district bUdget files and payroll, vehicle
logbooks, laboratory and radiography department records,
interviews with the architect, hospital administrator and
medical superintendent, and various medical supply
companies. Recurrent and capital health system costs used
gross salary and expenditure rather than budgeted figures
as appropriate and capital costs were annualised using a
discount rate of 8%. To estimate patient costs, a structured
questionnaire was administered to all 48 patients in the
Hlabisa tuberculosis ward awaiting discharge to community-
based directly observed therapy at the time of the study. We
enquired about time and travel costs associated with clinic
visits, number of dependants, employment and other
income-generating activities, impact of admission on self
and others, and amount of lost income.
Only costs of treating new adult patients after diagnosis
are reported here. Comparisons between strategies can
therefore be made and the cost of treating other categories
of patient (e.g. retreatment cases that require longer
hospitalisation and different drug regimens) can be
estimated from the data presented. We did not consider the
positive cost implications of improved control and
subsequent reduced transmission because these are largely
speculative.
The analysis focuses on average costs (total cost
expended divided by the total number of patients treated)
because we consider these to be more directly relevant than
marginal costs. An average cost gives a better indication of
the overall cost of a programme and thus allows a more
rigorous comparison; marginal costs are more influenced by
underutilisation within a system and do not account for
costs that are incurred for all patients who use a health care
system. Marginal costs (cost of managing the last patient)
are lower than average costs if there is spare capacity within
the system. For marginal cost calculations, staff and building
costs were assumed to be zero, because if they are in place
but underutilised then the opportunity cost of using them for
an additional patient is zero. All other costs were assumed
to be the same as those reported for average costs.
Marginal costs could not be calculated for sanatorium care.
In calculating cost-effectiveness, it was assumed that
patients not completing treatment defaulted at hospital
discharge.
Results
At a cost of R3 799 per patient cured, the current Hlabisa
strategy was the most cost-effective (Table 11), followed by
the national strategy (R9 940). Hospital-based care is
expensive (R16 950 per patient treated in Hlabisa prior to
1991). Care in a sanatorium is also expensive ({R11 145 per
patient cured) even though the cost per patient per day is
lower than in a district hospital (R40 in sanatoria v. R119).
Despite very different approaches, a similar proportion
(71 - 88%) of the cost of treating tuberculosis lies with the
health service (Table 11). The absolute cost to the patient was
lowest wrth strategy 1 (R394); lengthy hosprtalisation does
not make treatment cheaper for patients. Marginal costs
were also lowest for strategy 1.
Table 11. Costs and cost-effectiveness of alternative tuberculosis management strategies (rands)
Health system Patient Total Cost per Marginal
Strategy cost (%) cost (%) cost (%) patient cured" cost
Hlabisa (current) 2767 (88) 394 (12) 3161 (100) 3799 866
Hlabisa (pre-1991) 14814 (87) 2136 (13) 16950 (100) 98307 3974
Department of Health 7851 (87) 1 225 (13) 9076 (100) 9940 2174
SANTA' 7473 (71) 3115(29) 10588 (100) 11 145 Unknown
• Measure of cost-effectlVeness_
- Based on COSt per O3y =A~.
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The cost of each of the items that makes up the total cost
to the health service is shown in Table HI. The greatest cost
is hospitalisation (R119 per day). Even the most expensive
drug regimen (R157 for a 6-month course under strategy 3)
is equivalent to just 1.3 days in hospital. It is worth
highlighting the low cost of the supervision component of
strategy 1: including salary and transport costs, the total
cost of supervising each patient averages RS03, equivalent
to just 4.2 days in hospital.
Table IV lists the components of the cost borne by
patients. Visiting hospital for care is expensive (R42 per
Visit), as is time spent in hospital (R17 per day). Being
supervised at a community clinic is cheap (R3), and it is
cheaper still for the patient when supervision is by a non-
health worker (R1). Patient costs are related to travel costs
and lost income.
Table IV. Components of costs for patients treated in Hlabisa
Table Ill. Components of health system costs in Hlabisa
Cost item Cost (rands)
1 day in hospital (excluding drugs 119
and investigations)
Average cost of a community clinic visit 28
(excluding drugs and investigations)
Average cost of a visit by a.community health worker 7
Average cost to the health system of a DOT visW 7
Drugs (average cost per patient): Hlabisa (until 1991) 223
Drugs (average cost per pattent): Hlabisa (current) 157
Drugs (average cost per patient): 151
Department of Health guidelines
Average cost of supervision per patient 167
(including vehicle and field worker costs)
Programme management (average cost per patient)t 24
X-ray (average cost) 24
Sputum examination (average cost) 7
• Assumes pattern of DOT in Hlablsa in 1994': (56% supervised by non-health
workers and 44% by health workers).
t Assumes 20% of a medical office,-'s time is devoted to these duties.
DOT ~ directly observed the,-apy.
Item
Average cost
(rands)
Average cost of a visit to a village clinic 11
Average cost of a visit to hospital 42
Average cost of a village clinic DOT visit 3
Average cost of a community health worker DOT visit 2
Average cost of a non-health worker DOT visit 1
Total average cost of a DOT visit in Hlabisa' 2
Average cost of a day in hospital 17
DOT", directly observed therapy.
• Assumes pattern 01 DOT lfI Hlabisa in 199~' \56% supervised by non-health workers
and 44% by health workers).
In Table V costs of items contributing to health system
costs for each of the strategies are compared.
Hospitalisation accounts for most of this cost, and the
proportionate cost rises with length of stay. Importantly,
costs of other items vary little between strategies, and the
costs of drugs are relatively minor health system costs.
Similarly, for costs borne by patients (Table VI)
hospitalisation accounts for most of the cost.
Table V. Comparative health system costs of alternative strategies
Cost in rands (% of total)
Item Strategy 1 Strategy 2 Strategy 3 Strategy 4
Days in hospital 2083 (75) 14280 (96) 7140 (92) 7280 (97.5)
Drugs 157 (6) 223 (2) 151 (2) 151 (2)
Microscopy/radiology NIA 155 (1) 42 (0.5) 42 (0.5)
Visits for DOT/collection of treatment/check-ups 336 (12) 156 (1) 494 (6) NIA
Supervision (1 vehicle and 2 fieldworkers) 167 (6) NIA N/A NIA
Programme management 24 (1) NIA 24 (0.5) N/A
---
--
Total 2767 (100) 14814 (100) 7851 (100) 7473 (100)
• Assumes 20% of a medical officer's time is devoted to these duties.
DOT " directly obsaved tnempy; !'lA "'- f10t applicable.
Suategy: 1. Hlabisa (current) - 17.5 days in hospital; 2. Hlabisa (pre-1991) - 120 days in hospital: 3. Department of Health - 60 days in hospital; 4. SANTA - 182 days in
hospital @ R4C p€f day.
Table VI. Comparative patient costs of alternative strategies
Cost in rands (% of total)
Item Strategy 1 Strategy 2 Strategy 3 Strategy 4
Days in hospital
Visits for DOT/collection of treatment/check-up
Total
298 (76)
96 (24)
394 (100)
2040 (96)
96 (4)
2136 (100)
1 020 (83)
205 (17)
1 225 (100)
3094 (99.5)
21 (0.5)
3115 (100)
DOT" directly obs€lVed therapy.
Strategy: ,. Hlabisa (current) - 17.5 days in hospital; 2. Hlabisa (pre--1991) - 120 days in hoophaJ: 3. Department of Health - 60 days in hospital; 4. SANTA - 182 days in a
sanatonum_
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Discussion
Our results show that the current approach to tuberculosis
management in Hlabisa is both cheap and cost-effective.
The current strategy is 28 times more cost-effective than the
approach employed prior to 1991, and 2.7 times more cost-
effective than the national strategy, were this to be
employed in the district with an initial period of
hospitalisation. Community-based care is three times more
cost-effective than sanatorium-based care.
Cure rates in Hlabisa increased from 17% in 1990 to 81 %
between 1991 and 1994, while the cost of curing a patient
fell from R98 307 to R3 799. This illustrates the positive
achievements in improved effectiveness and reduced cost
that can be achieved at district level with the introduction of
community-based directly observed therapy. The main
reason for the current low cost in Hlabisa is the short period
of hospitalisation (Table V); all other components of the cost
of tuberculosis management ~ncluding drugs) are relatively
small when compared with the cost of hospital care.
Community-based care similarly reduces absolute patient
costs (fable VI). The reduced cost to both the health service
and the patient through the use of non-health workers is
substantial (fable IV).
It is not appropriate simply to reduce the length of
hospital stay in order to cut costs, although it is known that
hospitalisation per se is not essential to the management of
tuberculosis and that community-based directly observed
therapy is a highly effective alternative. 1!> To be rational, a
policy of reduced hospital stay must be linked to a policy of
strong and effective community-based care. Our results
show that community-based care is cost-effective.
Compliance is high in the Hlabisa programme and it would
seem that this is, at least in part, because of the low cost
and high convenience to the patient of community-based
directly observed therapy. A visit to a non-health worker in
our study did not require any monetary expenditure; the
small cost to the patient (R1) is a reflection of time lost from
income-generating activity. Visits to clinics (R4) and
particularly to hospital (R42) are more expensive because
travel costs rise and time lost from work increases.
When the emphasis of care is shifted from hospital to
community, total costs are reduced and improved cost-
effectiveness is possible. The cost of supervision in Hlabisa
is not high: the total cost to the health service of overall
supervision for each patient (including delivery to supervisor
and monthly checks of supervisor) is R503, eqUivalent to the
cost of 4.2 days in hospital. Employing field staff and buying
vehicles to run a community-based directty observed
therapy programme can be an attractive economic option in
this setting.
Sanatorium-based care is cheaper than hospitalisation
because sanatoria do not provide the other services and
staff that are found in a district hospital. The cost per
patient-day is substantially lower in sanatoria than hospitaL
However, even relatively cheap institutional care is more
expensive and hence less cost-effective than community-
based care. Although more patients with tuberculosis do
require lengthy hospitalisation in the HIV era, even with the
high seroprevalence levels observed in our setting, 90% of
patients are successfully managed as outpatients.'i
Can our findings be applied to the rest of South Africa?
A similar service was successfully provided in Pinetown
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20 years ago (G M Short - personal communication), and
the same approach is currently being implemented in the
Nkandla health district of Kwazulu-Natal (G Dean -
personal communication). Now that the system has been
piloted, audited and costed, there seems to be no inherent
reason why the key components of short hospital stay and a
strong community-based directly observed therapy
programme could not be implemented in other parts of
South Africa, although actual implementation would need to
be gUided by local circumstances.
This approach to tuberculosis management is affordable
within current budgetary constraints, is implementable within
existing infrastructure, and offers hope for coping with the
increased tuberculosis caseload. Our study provides
important cost and cost-effectiveness data on alternative
tuberculosis management strategies in South Africa, data
that were not previously available. The findings show that a
simplified approach to tuberculosis management based on
short hospital stay and a strong community programme is
cost-effective. Policy-makers may wish to consider applying
aspects of these findings to their decisions about what form
an effective tuberculosis control strategy in South Africa
should take. Our findings support the goals of the new
national tuberculosis control programme.
This work is a result of the Hlabisa-Uverpool HIV Unk, funded
by the British Government Overseas Development Administration
in partnership with the Medical Research Council and the
KwaZulu-Natal Provincial Health Department. The valuable
assistance with data collection by Ms Xoli Mfeka, Centre for
Health and Social Studies, who was funded by Health Systems
Tn,lst to join the Unk's Partnership in Training Initiative, is also
acknowledged. A detailed report is available from the authors.
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